Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer

What is the purpose of this trial?

This randomized phase III trial studies how well stereotactic body radiation therapy works compared to intensity-modulated radiation therapy in treating patients with stage IIA-B prostate cancer. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Stereotactic body radiation therapy is a specialized radiation therapy that sends x-rays directly to the tumor using smaller doses over several days and may cause less damage to normal tissue. Stereotactic body radiation therapy may work better in treating patients with prostate cancer.

Participation Guidelines

Ages: 18 years and older

Gender: Male only

NRG Oncology

Start Date: 05/15/2018

End Date: 04/30/2021

Last Updated: 07/31/2018

Study HIC#: 2000022286

Get Involved

For more information about this study, contact:
Jennifer Pope
+1 203-737-5801

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image